Last edition
News about "OSE Immunotherapeutics"
New patent grant to OSE Immunotherapeutics by EPO
OSE Immunotherapeutics receives European patent covering novel myeloid immune checkpoint target, CLEC-1 for cancer treatment
OSE Immunotherapeutics | 03/05/2022 | By Sudeep Soparkar | 502
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members